The rise of immersive technology is changing the way the pharmaceutical industry operates, offering a more immersive and interactive experience. Applying this technology, companies can better educate, inform, and entertain stakeholders in drug development, clinical trials, and patient engagement.
The embracement of this technology give companies a competitive advantage in the market. That’s why companies like 3Dforscience are leading the way in developing scientific communication solutions that can transform the pharma industry. As the demand continues to increase, it’s vital for companies to stay on top of this trend and incorporate it into their business strategies.
DebioPharm: an opportunity to explore innovative pharmaceutical solutions
Debiopharm Pharma is a leading independent biopharmaceutical company headquartered in Switzerland. With a commitment to developing tomorrow’s standard of care to cure cancer and infectious diseases, Debiopharm Pharma is involved in drug development, drug manufacturing, and digital health investment. Since its inception in 1979, the company has been dedicated to in-licensing innovative compounds and developing them into medicines for out-licensing.
Recently, Debiopharm Pharma hosted a Digital Day in Lausanne to showcase its commitment to innovation in the pharma industry. The event brought together staff, stakeholders, and external guests to embrace cutting-edge technologies like AI and spearhead pioneering projects. Among the guests were Javier M Floren, and Juan Castillo, who were thrilled to present 3DforScience – Global Scientific Communications immersive technology and demonstrate how their visualization solutions applied to pharma and biotech a game-changer.
As the event progressed, it became clear that Debiopharm Pharma and 3Dforscience share a common goal of advancing innovation in the pharma industry. 3Dforscience’s cutting-edge technologies have the potential to revolutionize the way companies communicate science with their stakeholders, including healthcare professionals, regulators, and patients.
During the event, 3Dforscience demonstrated how their technology can be used to improve patient experiences, communication and innovation. The company showcased its immersive technology as Virtual Reality, which provides a 3D view of drugs and their mechanisms of action, one of the expert fields of Debiopharm.
This visualization technology can help stakeholders better understand how drugs work, their benefits, and potential side effects. Additionally, 3Dforscience’s technology can help in the development of medical devices and surgical procedures by providing a 3D view of anatomy and physiology. Thanks to Dawn Haughton-Bonine, Tanja Dowe, Angela Zubel, and the Debiopharm ecosystem like David Del Bourgo and Julien Cottineau from WhiteLab Genomics or Diane Jooris from Oncomfort.
Events like Debiopharm’s Digital Day are crucial for bringing together industry leaders and driving innovation in the pharma industry. We applaud Debiopharm for taking a leadership role and setting an excellent example for others to follow.
How 3DforScience can help?
3DforScience is a scientific communication company specializing in visual content for the life science sector. We are a passionate creative team of scientists, marketers, artists, and animators with a shared aim: to help you improve your scientific communication with innovative and unique creative solutions.
We can help to boost your scientific communication capabilities within the biotechnological/ molecular biology fields by designing unique creative solutions such as 3D animation videos or illustrations.
Would you like to bring your scientific messaging to life? Contact us. We would be pleased to provide you with a unique creation.
